The National Aeronautics and Space Administration (NASA) cannot afford a wide margin of error nor an invasive approach to monitoring astronauts’ heart performance while they are floating in space. That’s why NASA invited Dr. Bo Sramek to develop its noninvasive cardiac system for evaluating ventricular parameters. The invented product NCCOM3 (Noninvasive Continuous Cardiac Output), was medically verified in 1985 by more than 50 clinical studies to be a legitimate noninvasive counterpart to the invasive measurement of cardiac output (CO) – Thermodilution, TD.

In 1986, NASA hired Dr. Bo Sramek as the Principal Investigator to use TEB for continuous assessment of astronaut’s Ejection Fraction (EF) amid space mission. The noninvasive properties of NCCOM3 system represent not only the state-of-the-art technology, but the future of medical development as well.